127 related articles for article (PubMed ID: 37533242)
41. Application of multislice spiral CT angiography on transcatheter arterial chemoembolization for hepatocellular carcinoma.
Huang JH; Fan WJ; Li CJ; Gu YK; Zhang L; Gao F; Lu LW; Li WQ
Ai Zheng; 2009 Feb; 28(2):159-63. PubMed ID: 19550129
[TBL] [Abstract][Full Text] [Related]
42. Carboplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Yamashita F; Tanaka M; Andou E; Yutani S; Kato O; Tanikawa K
Oncology; 1997; 54(1):28-33. PubMed ID: 8978589
[TBL] [Abstract][Full Text] [Related]
43. Use of carbon dioxide microbubble-enhanced sonographic angiography for transcatheter arterial chemoembolization of hepatocellular carcinoma.
Hashimoto M; Watanabe O; Hirano Y; Kato K; Watarai J
AJR Am J Roentgenol; 1997 Nov; 169(5):1307-10. PubMed ID: 9353447
[TBL] [Abstract][Full Text] [Related]
44. [Digital subtraction angiography manifestation and interventional therapy of arteriovenous shunting in primary hepatocellular carcinoma of advanced stage].
Zhu Lz; Yang Rj
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):129-34. PubMed ID: 18458684
[TBL] [Abstract][Full Text] [Related]
45. Chemoembolization alone vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients.
Gao S; Zhang PJ; Guo JH; Chen H; Xu HF; Liu P; Yang RJ; Zhu X
World J Gastroenterol; 2015 Sep; 21(36):10443-52. PubMed ID: 26420971
[TBL] [Abstract][Full Text] [Related]
46. HAIC versus TACE for patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
Liu J; Zhang J; Wang Y; Shu G; Lou C; Du Z
Medicine (Baltimore); 2022 Dec; 101(51):e32390. PubMed ID: 36595819
[TBL] [Abstract][Full Text] [Related]
47. Hepatic arterial infusion chemotherapy with fine-powder cisplatin and iodized-oil suspension in patients with intermediate-stage and advanced-stage (Barcelona Clinic Liver Cancer stage-B or stage-C) hepatocellular carcinoma: multicenter phase-II clinical study.
Takaki H; Yamakado K; Tsurusaki M; Yasumoto T; Baba Y; Narimatsu Y; Shimohira M; Yamaguchi M; Matsuo K; Inaba Y; Mikami K; Watanabe R; Nishida N; Anai H; Kakizawa H; Hirota S
Int J Clin Oncol; 2015 Aug; 20(4):745-54. PubMed ID: 25432660
[TBL] [Abstract][Full Text] [Related]
48. History of Transcatheter Arterial Chemoembolization Predicts the Efficacy of Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma Patients.
Onishi H; Nouso K; Takaki A; Oyama A; Adachi T; Wada N; Takeuchi Y; Shiraha H; Okada H
Acta Med Okayama; 2022 Dec; 76(6):695-703. PubMed ID: 36549772
[TBL] [Abstract][Full Text] [Related]
49. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A.
Lee BH; Lee DS; Cho CW; Yun SS
World J Surg Oncol; 2019 Aug; 17(1):143. PubMed ID: 31416447
[TBL] [Abstract][Full Text] [Related]
50. Change of indocyanine green clearance ability and liver function after transcatheter intra-arterial therapies and its impact on outcomes of resectable hepatocellular carcinoma: a retrospective cohort study.
Gan YX; Yang ZL; Pan YX; Ou-Yang LY; Tang YH; Zhang YJ; Chen MS; Xu L
Int J Surg; 2024 May; 110(5):2832-2844. PubMed ID: 38363991
[TBL] [Abstract][Full Text] [Related]
51. A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights.
Xie DY; Zhu K; Ren ZG; Zhou J; Fan J; Gao Q
Hepatobiliary Surg Nutr; 2023 Apr; 12(2):216-228. PubMed ID: 37124695
[TBL] [Abstract][Full Text] [Related]
52. A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma.
Kobayashi S; Fukushima T; Ueno M; Moriya S; Chuma M; Numata K; Tsuruya K; Hirose S; Kagawa T; Hattori N; Watanabe T; Matsunaga K; Suzuki M; Uojima H; Hidaka H; Kusano C; Suzuki M; Morimoto M
BMC Cancer; 2022 May; 22(1):517. PubMed ID: 35525913
[TBL] [Abstract][Full Text] [Related]
53. Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: Radiologic and Clinical Factors Predictive of Survival.
Kim B; Won JH; Kim J; Kwon Y; Cho HJ; Huh J; Kim JK
AJR Am J Roentgenol; 2021 Jun; 216(6):1566-1573. PubMed ID: 33852336
[No Abstract] [Full Text] [Related]
54. Quantitative Real-Time Fluoroscopy Analysis on Measurement of the Hepatic Arterial Flow During Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Comparison with Quantitative Digital Subtraction Angiography Analysis.
Lin YY; Lee RC; Guo WY; Chu WF; Wu FC; Gehrisch S
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1557-1563. PubMed ID: 27485268
[TBL] [Abstract][Full Text] [Related]
55. Comparative efficacy and safety of multimodality treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: patient-level network meta-analysis.
Leung JH; Wang SY; Leung HWC; Chan ALF
Front Oncol; 2024; 14():1344798. PubMed ID: 38434681
[TBL] [Abstract][Full Text] [Related]
56. Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma.
Feng X; Feng GY; Tao J; Ao YP; Wu XH; Qi SG; Shi ZR
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10505-10518. PubMed ID: 37284841
[TBL] [Abstract][Full Text] [Related]
57. Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma.
Tsai WL; Sun WC; Chen WC; Chiang CL; Lin HS; Liang HL; Cheng JS
Medicine (Baltimore); 2020 Aug; 99(32):e21489. PubMed ID: 32769883
[TBL] [Abstract][Full Text] [Related]
58. Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma.
Fu S; Xu Y; Mao Y; He M; Chen Z; Huang S; Li D; Lv Y; Wu J
Cancer Med; 2024 May; 13(9):e7105. PubMed ID: 38686567
[TBL] [Abstract][Full Text] [Related]
59. Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE).
Nakano MM; Yamamoto A; Nishida N; Hamuro M; Hamamoto S; Jogo A; Sohgawa E; Kageyama K; Minami T; Miki Y
Jpn J Radiol; 2019 Jul; 37(7):543-548. PubMed ID: 31055710
[TBL] [Abstract][Full Text] [Related]
60. Pseudo-capsulated Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy Versus Transcatheter Arterial Chemoembolization.
An C; Yao W; Zuo M; Li W; Chen Q; Wu P
Acad Radiol; 2024 Mar; 31(3):833-843. PubMed ID: 37487879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
